Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00098293
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Who this might be right for
HIV-1
ViiV Healthcare 916
Not applicableUnknownNCT04894357
What this trial is testing

Impact of V106I on Resistance to Doravirine

Who this might be right for
HIV-1-infection
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental 50
Not applicableStudy completedNCT02140944
What this trial is testing

IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence

Who this might be right for
HIV Infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 2
Not applicableStudy completedNCT00219934
What this trial is testing

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

Who this might be right for
HIV Infections
Rockefeller University 399
Not applicableStudy completedNCT02063880
What this trial is testing

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Who this might be right for
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
University of Washington 183
Early research (Phase 1)Study completedNCT02194179
What this trial is testing

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 92
Early research (Phase 1)WithdrawnNCT03044379
What this trial is testing

Dapivirine Gel Rectal Safety and PK Study

Who this might be right for
HIV 1 Infection
International Partnership for Microbicides, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT02415595
What this trial is testing

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 210
Testing effectiveness (Phase 2)Ended earlyNCT01199731
What this trial is testing

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 30
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Early research (Phase 1)Study completedNCT00412477
What this trial is testing

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 18
Testing effectiveness (Phase 2)Study completedNCT00120185
What this trial is testing

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Post-approval studies (Phase 4)UnknownNCT04225325
What this trial is testing

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

Who this might be right for
HIV-1-infection
ADRIANO LAZZARIN, MD 112
Not applicableStudy completedNCT00001121
What this trial is testing

Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Not applicableStudy completedNCT03624413
What this trial is testing

InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media

Who this might be right for
HIV-1-infectionAdolescent Behavior
Emory University 80
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Early research (Phase 1)Study completedNCT05261191
What this trial is testing

MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus I InfectionImmunodeficiency Virus Type 1, HumanHuman Immunodeficiency Virus Type 1
MacroGenics 17
Testing effectiveness (Phase 2)Ended earlyNCT00002420
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Next Page